Media Centre
Latest press releases
-
AstraZeneca to present overall survival data from four pivotal Phase III trials in Presidential Symposia at ESMO 2026 featuring Sone-Ve, Imfinzi, Tagrisso and Orpathys
-
AstraZeneca announces new strategic collaboration with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases
-
Efzimfotase alfa showed numerical improvement in Six-Minute Walk Test achieving mean difference of 17.05 metres vs placebo in treatment-naïve adolescents and adults with hypophosphatasia at week 25 in HICKORY Phase III trial
-
Alexion to showcase Phase III data in hypophosphatasia and hypoparathyroidism at ASBMR 2026 Annual Meeting
-
AstraZeneca opens new global strategic R&D centre in Kendall Square, Cambridge, Massachusetts
-
AstraZeneca completes equity investment in Summit Therapeutics
Medical Releases
These press releases are specifically for health specialist/medical media and are not for consumer press.
